Publications by authors named "Honore Zougmore"
Background: Data on the management of Hepatitis B-Delta (HB-D) by hepatogastroenterologists (HGs) practicing in nonacademic hospitals or private practices are unknown in France.
Objective: We aimed to evaluate the knowledge and practices of HGs practicing in nonacademic settings regarding HB-D.
Methods: A Google form document was sent to those HGs from May to September 2021.
Background: The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. The aims of this article are which follows: To gather the practices of hepatogastroenterologists or pulmonologists practitioners regarding the diagnosis and management of the hepatic hydrothorax.
Methods: Practitioners from 13 French- speaking countries were invited to answer an online questionnaire on the hepatic hydrothorax diagnosis and its management.
Article Synopsis
- A noninvasive medical device utilizing ultrasound elastography, specifically Shear Wave Elastography (SWE), was evaluated against Fibroscan® (FS) to measure liver hardness in patients with chronic liver diseases.
- Between January and October 2017, a total of 476 patients were assessed, revealing a significant correlation between SWE and FS measurements, especially in patients with chronic viral hepatitis.
- The study concluded that SWE is a reliable alternative to FS for evaluating liver fibrosis, providing noninvasive options even for patients who could not undergo FS testing.
Patients with cirrhosis are prone to develop bacterial infections, which consist in one of the major precursors of Acute-on-Chronic Liver Failure (ACLF) and are responsible for a high mortality rate. In recent years, the management of bacterial infections in patients with cirrhosis has become increasingly complicated due to a change in bacterial ecology associated with a higher rate of cocci gram positive bacteria in Europe and America along with the emergence of a multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria leading to a decrease in the efficacy of empirical strategies based on the administration of third-generation cephalosporins. MDR and XDR now account for about 40% of the infections worldwide, and up to 70% in India.
View Article and Find Full Text PDFIntroduction: Sofosbuvir is the first directly-acting antiviral for the treatment of hepatitis C virus. First, the regimens were combinations with sofosbuvir+ribavirin (SR) or with sofosbuvir+ribavirin and pegylated-interferon α-2a (SPR) with cure rates around 90%. The aim of this study was to report the results of these combinations in 'real-life' in France.
View Article and Find Full Text PDF